Virtusa Partners with the IBRI to Drive Innovation and Accelerate Therapy Research
November 07 2018 - 11:05AM
Virtusa Corporation (NASDAQ GS:VRTU), a global provider of
digital strategy, digital engineering, and IT outsourcing services
that accelerates business outcomes for its clients, today announced
its collaboration with the Indiana Biosciences Research Institute
(IBRI) to accelerate Life Sciences research and development. This
partnership will leverage Virtusa’s vLife open innovation platform
to enable organizations to work in a connected ecosystem that
allows them to access, validate, and adopt other firms’
technologies (e.g. analytics, machine learning, artificial
intelligence) and enhance the entire research and development
process.
“Partnering with Virtusa will help the IBRI to
achieve its objective of enabling regional, large life sciences
companies to access data and technologies from a variety of
organizations,” said Daniel H. Robertson, PhD, research fellow
& vice president of Digital Technology, and director of the
Applied Data Sciences Center for the IBRI. “Through the vLife open
innovation platform, we’re exploring enabling Life Sciences firms
to accelerate progress towards finding next-level treatments by
providing seamless access to focused, timeline-driven collaboration
with universities, government entities, healthcare providers, and
other research institutes and organizations.”
Virtusa’s vLife open innovation platform is
designed to engage teams to innovate and operationalize solutions
faster. To enable a collaborative environment it uses open APIs
that allow for the secure and speedy flow of information. As part
of this vLIfe implementation, Virtusa and the IBRI will perform
comparative analyses of synthetic data with real-world data of
diabetes patients to better understand how synthetic data, which is
not constrained by HIPAA regulations, can accelerate research.
These analyses will measure the viability of synthetic data as an
alternative to real-world datasets to drive research with the
IBRI’s partners.
“The strategic partnership with the IBRI allows
Virtusa to focus on supporting our client’s near-term objective of
enabling accelerated discovery of diabetes treatment and its many
long-term objectives through modern, mature, and dynamic
technologies,” said Anthony Lange, senior vice president of Life
Sciences, Virtusa. “This partnership aims to enable industry
connections to drive innovation through extensive collaborative
research on Virtusa’s vLife open innovation platform.”
Virtusa’s Life Sciences practice helps companies
navigate the challenging landscape of drug pricing pressure, the
patent cliff, increasingly stringent regulations, growth into
emerging markets, and a shift to outcome-based payment structures.
With a focus on developing and harnessing connected care platforms
that are both data and AI-centered, Virtusa helps its clients to
deliver better patient outcomes at a lower cost.
For more information on Virtusa’s vLife Open Innovation
Platform, please visit: https://www.virtusa.com/vlife/
For more information on Virtusa’s Life Sciences
Practice, visit:
https://www.virtusa.com/industry/life-sciences/
About IBRI
The Indiana Biosciences Research Institute
(IBRI) is a 501(c)(3) not-for-profit and independent applied
research institute formed in 2013. The IBRI is focused on discovery
and applied research to facilitate the development of technologies
and innovations aimed at improving human and animal health,
agriculture and the environment. Target areas are diabetes,
metabolic disease and poor nutrition, and related applied data
science and analytics. More at
http://www.indianabiosciences.org
About Virtusa
Corporation
Virtusa Corporation (NASDAQ GS: VRTU) is a
global provider of Digital Business Transformation, Digital
Engineering, and Information Technology (IT) outsourcing services
that accelerate our clients’ journey to their Digital Future.
Virtusa serves Global 2000 companies in Banking, Financial
Services, Insurance, Healthcare, Telecommunications, Media,
Entertainment, Travel, Manufacturing, and Technology
industries.
Using a combination of digital strategy, digital
engineering, business implementation, and IT platform modernization
services, Virtusa helps clients execute successful end-to-end
digital business transformation initiatives.
Virtusa engages its clients to re-imagine their
business models and develop strategies to defend and grow their
business by introducing innovative products and services,
developing distinctive digital consumer experiences, creating
operational efficiency using digital labor, developing operational
and IT platforms for the future, and rationalizing and modernizing
their existing IT applications infrastructure. As a result, its
clients are simultaneously able to drive business growth through
digital-first customer experiences, while also consolidating and
modernizing their IT application infrastructure to support digital
business transformation.
Holding a proven record of success across
industries, Virtusa readily understands its clients' business
challenges and uses its domain expertise to deliver innovative
applications of technology to address its clients’ critical
business challenges. Examples include building the world's largest
property & casualty claims modernization program; one of the
largest corporate customer portals for a premier global bank; an
order to cash implementation for a multinational telecommunications
provider; and digital transformation initiatives for media and
banking companies.
Founded in 1996 and headquartered in
Massachusetts, Virtusa has operations in North America, Europe, and
Asia.
© 2018 Virtusa Corporation. All rights
reserved.
Virtusa, Accelerating Business Outcomes, BPM
Test Drive and Productization are registered trademarks of Virtusa
Corporation. All other company and brand names may be
trademarks or service marks of their respective holders.
Contact: Amy Legere
Organization: Greenough
Email: alegere@greenough.biz
Phone: (617) 275-6517
Virtusa (NASDAQ:VRTU)
Historical Stock Chart
From Mar 2024 to Apr 2024
Virtusa (NASDAQ:VRTU)
Historical Stock Chart
From Apr 2023 to Apr 2024